WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

*Nibras Hamid Hussain, Hiba D. Al Ameri and Jawad K. Al-Diwan

ABSTRACT

Introduction: Most cases of breast cancer occur in women. It has a 1.4 million yearly worldwide incidence rate, making it the second most prevalent malignancy in women behind lung cancer. The study's objective is to determine if utilising GM5 to predict breast cancer risk in Iraqi women and its relationship to Birad category is practical. Method: The September–November 2022 cross-sectional research recruited 100 breast clinic women at AL-Yarmouk Teaching Hospital. convenience sampling. The ladies verbally agreed. A questionnaire based on the National Cancer Institute's online Breast Cancer Risk Assessment Tool (BCRAT), also known as Gail Model, and women's sociodemographic characteristics collected the data. All patients provide marital status, female education level, employment, residence, past breast disease, chest radiation, first-degree relative, biopsy, clinical breast examination, and hormone replacement treatment times. Results: A majority of them have never had breast disease, 100% have never been exposed to breast radiation, 23% have one first-degree relative, 2% and 3%, respectively, have positive clinical breast examination and biopsy results, and 85% have never received hormone therapy. The average age is 51 years and 8 months, and 93% of women are married, 49% are in primary school, and 79% are housewives. 81% of women are at low risk for breast cancer, compared to 19 women (19%) who have a high risk. Risks of GS5 breast cancer are significantly correlated with MAMMO (Birad category). Conclusion: Five-year breast cancer risk for women is moderate. High-risk five-year breast cancer chances are (2.5 0.76) and low-risk five-year risks are (1.046 0.36). All B4 (Birad category) women have good GS5 scores.